Clinical trials data
Symbol Coding in healthy volunteer trials: 56 registered studies
Every registered healthy volunteers study on ClinicalTrials.gov that names Symbol Coding in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered healthy volunteers studies name it in an outcome measure
- 56
- Name it in a primary outcome, 32%
- 18 of 56
Tests named in the same studies
- 1
Trail Making Test8 studies, 3 as a primary outcome
- 2
Stroop Color-Word Test8 studies, 2 as a primary outcome
- 3
Digit Span Test6 studies, 4 as a primary outcome
- 4
Verbal Learning5 studies, 3 as a primary outcome
- 5
Psychomotor Vigilance Task5 studies, 1 as a primary outcome
- 6
Verbal Fluency4 studies, 1 as a primary outcome
- 7
Matrix Reasoning3 studies, 2 as a primary outcome
- 8
Paired Associate Learning3 studies, 2 as a primary outcome
- 9
Selective Reminding Task3 studies, 2 as a primary outcome
- 10
Task Switching Test3 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 2 | 2 |
| 2011 | 4 | 0 |
| 2012 | 0 | 0 |
| 2013 | 2 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 0 |
| 2017 | 2 | 1 |
| 2018 | 4 | 2 |
| 2019 | 1 | 1 |
| 2020 | 3 | 0 |
| 2021 | 4 | 2 |
| 2022 | 3 | 2 |
| 2023 | 2 | 1 |
| 2024 | 6 | 1 |
| 2025 | 13 | 3 |
| 2026 | 3 | 0 |
Phases and study sizes
By phase
- Early phase 12 studies, 1 as a primary outcome
- Phase 118 studies, 2 as a primary outcome
- Phase 1/21 studies, 0 as a primary outcome
- Phase 21 studies, 0 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 44 studies, 0 as a primary outcome
- Not applicable22 studies, 11 as a primary outcome
- Observational6 studies, 3 as a primary outcome
Participants per study
- Phase 124 median, 12 to 46
- Not applicable74 median, 31 to 120
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 1 | 17 | 24 | 12 to 46 |
| Not applicable | 22 | 74 | 31 to 120 |
When healthy volunteer trials measure it
Latest time point of each outcome
- Within a day21 outcomes, 6 as a primary outcome
- Up to 4 weeks11 outcomes, 3 as a primary outcome
- 1 to 3 months15 outcomes, 7 as a primary outcome
- 3 to 6 months3 outcomes, 1 as a primary outcome
- 6 to 12 months4 outcomes, 0 as a primary outcome
- 1 to 2 years1 outcomes, 1 as a primary outcome
- No duration given1 outcomes, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
55 of the 56 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting12 studies, 2 as a primary outcome
- Active, not recruiting2 studies, 1 as a primary outcome
- Completed33 studies, 12 as a primary outcome
- Stopped early2 studies, 1 as a primary outcome
- Status unknown7 studies, 2 as a primary outcome
What they test
- Behavioral10 studies, 6 as a primary outcome
- Drug29 studies, 4 as a primary outcome
- Device3 studies, 2 as a primary outcome
- Dietary supplement7 studies, 2 as a primary outcome
- Procedure1 studies, 1 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Other6 studies, 3 as a primary outcome
- None given4 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States20 studies, 11 as a primary outcome
- United Kingdom5 studies, 0 as a primary outcome
- Denmark4 studies, 0 as a primary outcome
- Finland4 studies, 0 as a primary outcome
- Spain4 studies, 0 as a primary outcome
- Belgium3 studies, 1 as a primary outcome
- Italy3 studies, 2 as a primary outcome
- Canada2 studies, 0 as a primary outcome
- France2 studies, 1 as a primary outcome
- Germany2 studies, 0 as a primary outcome
- Hungary2 studies, 1 as a primary outcome
- Netherlands2 studies, 0 as a primary outcome
19 countries in all. A study with sites in several counts in each; 1 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed healthy volunteers studies that name Symbol Coding: 7 of 33, 21%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed healthy volunteers studies that name Symbol Coding | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 2, 6% | 776, 10% |
| Results on ClinicalTrials.gov only | 2, 6% | 1,139, 14% |
| A results paper only | 3, 9% | 1,711, 22% |
| Neither | 26, 79% | 4,327, 54% |
The 56 studies
56 studies match. 18 name Symbol Coding in a primary outcome. Median size 57 participants. Median time to the primary outcome: 5 weeks.
Loading 56 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 2 | 2 |
| 2011 | 4 | 0 |
| 2012 | 0 | 0 |
| 2013 | 2 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 0 |
| 2017 | 2 | 1 |
| 2018 | 4 | 2 |
| 2019 | 1 | 1 |
| 2020 | 3 | 0 |
| 2021 | 4 | 2 |
| 2022 | 3 | 2 |
| 2023 | 2 | 1 |
| 2024 | 6 | 1 |
| 2025 | 13 | 3 |
| 2026 | 3 | 0 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 17, other 39. Interventional 50, observational 6.
As a primary outcomeSecondary or other outcomeSymbol Coding
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07827651 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise, Sleep and sleep disorders | Participants64 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07783074 | Start2026 | PhaseObservational | ConditionsMultiple sclerosis, Healthy volunteers, COVID-19 and long COVID, Pain and fatigue | Participants122 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07623122 | Start2024 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants120 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07580820 | Start2025 | PhaseObservational | ConditionsMultiple sclerosis, Healthy volunteers | Participants32 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07511439 | Start2026 | PhasePhase 4 | ConditionsHealthy volunteers | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07505355 | Start2025 | PhaseObservational | ConditionsMultiple sclerosis, Healthy volunteers | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07267845 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07231497 | Start2025 | PhasePhase 3 | ConditionsSchizophrenia and psychosis, Healthy volunteers | Participants103 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07208279 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants16 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07195318 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07161518 | Start2025 | PhasePhase 4 | ConditionsHealthy volunteers | Participants10 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07119684 | Start2024 | PhaseNot applicable | ConditionsHealthy volunteers | Participants35 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07110896 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise, Anxiety, PTSD and OCD | Participants236 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07109245 | Start2025 | PhasePhase 4 | ConditionsHealthy volunteers | Participants35 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07050368 | Start2025 | PhasePhase 1 | ConditionsHealthy volunteers | Participants20 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07043452 | Start2025 | PhaseEarly phase 1 | ConditionsHealthy volunteers | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06931977 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers | Participants97 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06643637 | Start2024 | PhasePhase 1 | ConditionsHealthy volunteers | Participants16 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06616285 | Start2024 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants80 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06570369 | Start2024 | PhasePhase 1 | ConditionsDepression and bipolar disorder, Healthy volunteers | Participants26 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06431932 | Start2026 | PhasePhase 1/2 | ConditionsHealthy volunteers | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06425679 | Start2023 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants120 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06066281 | Start2023 | PhaseObservational | ConditionsHealthy volunteers | Participants480 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05974605 | Start2022 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise | Participants16 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05826314 | Start2022 | PhaseNot applicable | ConditionsHealthy volunteers | Participants75 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many healthy volunteer trials use Symbol Coding?
56 registered healthy volunteers studies on ClinicalTrials.gov name it in an outcome measure, 18 of them in a primary outcome: 9% of the condition's 656 studies with a cognitive outcome, against 9% of all of them. It is the 5th most named test in healthy volunteer trials.
Which tests do healthy volunteer trials use with Symbol Coding?
The Trail Making Test (8 studies), the Stroop Color-Word Test (8 studies) and the Digit Span Test (6 studies).
When do healthy volunteer trials measure Symbol Coding?
Half of the primary outcomes that name Symbol Coding are measured within 5 weeks of the start, and the middle half from the first day to 10 weeks. 18 primary outcomes give a duration.
How many completed healthy volunteer trials that use Symbol Coding have reported results?
7 of the 33 completed studies that name it, 21%, have reported results: 4 posted them on ClinicalTrials.gov, 5 have a results paper linked to the registry record, and 2 did both. The other 26 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Symbol Key Game and Symbol Coding as one test family, so this page counts their studies together.
Run Symbol Coding in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.